X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7888) 7888
Publication (1235) 1235
Book Review (105) 105
Book Chapter (91) 91
Dissertation (43) 43
Conference Proceeding (16) 16
Book / eBook (15) 15
Web Resource (9) 9
Magazine Article (6) 6
Data Set (5) 5
Journal / eJournal (3) 3
Paper (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4980) 4980
index medicus (4640) 4640
female (4231) 4231
human papillomavirus (3651) 3651
cervical cancer (3147) 3147
hpv (3139) 3139
adult (2489) 2489
vaccination (2217) 2217
cancer (2146) 2146
adolescent (2139) 2139
papillomavirus infections - prevention & control (2133) 2133
vaccines (2104) 2104
papillomavirus infections (2000) 2000
women (1833) 1833
middle aged (1563) 1563
prevalence (1535) 1535
male (1533) 1533
immunology (1529) 1529
young adult (1487) 1487
immunization (1461) 1461
hpv vaccine (1446) 1446
oncology (1401) 1401
infection (1367) 1367
uterine cervical neoplasms - prevention & control (1325) 1325
papillomavirus infections - epidemiology (1289) 1289
papillomavirus infections - virology (1249) 1249
prevention (1236) 1236
papillomavirus vaccines - administration & dosage (1214) 1214
uterine cervical neoplasms - virology (1176) 1176
cervical-cancer (1157) 1157
health aspects (1094) 1094
public, environmental & occupational health (1094) 1094
hpv vaccination (1002) 1002
risk factors (984) 984
infectious diseases (952) 952
united-states (939) 939
papillomaviruses (924) 924
research (917) 917
vaccine (902) 902
child (861) 861
article (851) 851
medicine, research & experimental (842) 842
young-women (838) 838
analysis (817) 817
aged (770) 770
health knowledge, attitudes, practice (765) 765
epidemiology (760) 760
virus diseases (754) 754
papillomaviridae - genetics (738) 738
risk (722) 722
papillomavirus vaccines - immunology (714) 714
papillomaviridae - isolation & purification (685) 685
papillomavirus infections - complications (683) 683
infections (665) 665
particle vaccine (649) 649
diagnosis (631) 631
hpv infection (631) 631
public health (624) 624
knowledge (620) 620
attitudes (612) 612
papillomavirus vaccines (611) 611
uterine cervical neoplasms - epidemiology (596) 596
obstetrics & gynecology (587) 587
papillomavirus vaccines - therapeutic use (584) 584
womens health (581) 581
cervical intraepithelial neoplasia (570) 570
genotype (570) 570
papillomavirus infections - diagnosis (570) 570
female genital diseases and pregnancy complications (545) 545
intraepithelial neoplasia (545) 545
adolescents (528) 528
cross-sectional studies (525) 525
dna (506) 506
research article (500) 500
surveys and questionnaires (496) 496
allergy and immunology (495) 495
human-papillomavirus (488) 488
efficacy (476) 476
virology (463) 463
papillomavirus infections - immunology (456) 456
uterine cervical neoplasms - diagnosis (456) 456
acceptability (447) 447
natural-history (442) 442
lesions (439) 439
cervix (436) 436
studies (432) 432
medicine, general & internal (428) 428
medicine (424) 424
microbiology (422) 422
papillomaviridae - classification (419) 419
human-papillomavirus vaccination (414) 414
cervical intraepithelial neoplasia - virology (413) 413
medical screening (413) 413
care and treatment (402) 402
medical research (401) 401
cytology (400) 400
genital warts (400) 400
men (382) 382
sexually transmitted diseases (381) 381
animals (375) 375
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7618) 7618
German (94) 94
French (87) 87
Spanish (80) 80
Japanese (31) 31
Korean (29) 29
Polish (26) 26
Swedish (18) 18
Chinese (12) 12
Portuguese (12) 12
Turkish (10) 10
Croatian (9) 9
Czech (8) 8
Italian (7) 7
Russian (5) 5
Hungarian (3) 3
Arabic (2) 2
Serbian (2) 2
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2015, Volume 11, Issue 7, pp. 1689 - 1702
This observer-blind study (clinicaltrials.gov NCT01462357) compared the immunogenicity and safety of 2 doses of the HPV-16/18 AS04-adjuvanted vaccine... 
y, year(s) | AAHS, aluminum hydroxyphosphate sulfate | CI, confidence interval | PBMC, peripheral blood mononuclear cells | ELISA, enzyme-linked immunosorbent assay | M, month(s) | ELISPOT, enzyme-linked immunosorbent spot assay | human papillomavirus (HPV) vaccines | HPV-6/11/16/18(3D), 3-dose schedule of the HPV-6/11/16/18 vaccine | safety | ANOVA, analysis of variance | female adolescents | 50 | PBNA, pseudovirion-based neutralisation assay | GMT, geometric mean antibody titer | ED | 2D, 2-dose | AS04, Adjuvant System containing 50 µg 3-O-desacyl-4 ′-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 µg Al | CMI, cell-mediated immunity | 3D, 3-dose | ) | SAE, serious adverse event | immunogenicity | HPV, human papillomavirus | IgG, immunoglobulin G | TVC, total vaccinated cohort | 3 | ATP-I, according-to-protocol immunogenicity cohort | effective dose producing 50% response | HPV-16/18(2D), 2-dose schedule of the HPV-16/18 vaccine | IFNγ, interferon | VLP, virus-like particle | administration schedule | GMR, geometric mean titer ratio | EU, ELISA unit | HPV-6/11/16/18(2D), 2-dose schedule of the HPV-6/11/16/18 vaccine | pIMD, potential immune-mediated disease | Administration schedule | Safety | Immunogenicity | Human papillomavirus (HPV) vaccines | Female adolescents | PBNA | TVC | enzyme-linked immunosorbent spot assay | pIMD | CLINICAL-TRIAL | potential immune-mediated disease | OF-STUDY ANALYSIS | ELISA unit | IMMUNOLOGY | NEUTRALIZATION ASSAY | 18(3D) | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | geometric mean antibody titer | BLIND PATRICIA TRIAL | CMI | 2-dose | pseudovirion-based neutralisation assay | AS04 | CERVICAL-CANCER | GMR | PBMC | GMT | MEMORY B-CELLS | according-to-protocol immunogenicity cohort | AAHS | PARTICLE VACCINE | SAE | human papillomavirus | HPV VACCINE | ELISA | ATP-I | month(s) | virus-like particle | 3-dose | geometric mean titer ratio | IgG | 2-dose schedule of the HPV-16 | HPV | 18 vaccine | IFN | 18(2D) | CD154 EXPRESSION | analysis of variance | ANOVA | serious adverse event | total vaccinated cohort | year(s) | ED50 | VLP | YOUNG-WOMEN | Adjuvant System containing 50 mu g 3-O-desacyl-4-monophosphoryl lipid A (MPL) adsorbed on aluminum salt (500 mu g Al3+) | peripheral blood mononuclear cells | aluminum hydroxyphosphate sulfate | immunoglobulin G | 3-dose schedule of the HPV-6 | HPV-16 | HPV-6 | 2-dose schedule of the HPV-6 | interferon | ELISPOT | enzyme-linked immunosorbent assay | confidence interval | cell-mediated immunity | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - adverse effects | Adjuvants, Immunologic - administration & dosage | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - immunology | Vaccine Potency | Humans | Alphapapillomavirus - immunology | Antibodies, Viral - blood | Immunity, Humoral | Time Factors | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 - administration & dosage | Papillomavirus Infections - prevention & control | Adolescent | Papillomavirus Vaccines - adverse effects | Female | Immunization Schedule | Papillomavirus Vaccines - immunology | Child | Immunity, Cellular | Papillomavirus Vaccines - administration & dosage | Antibodies, Neutralizing - blood | Medical and Health Sciences | Basic Medicine | Medicinsk bioteknologi | Medical Biotechnology | Medicin och hälsovetenskap | Immunologi inom det medicinska området | Immunology in the medical area | Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) | Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Human Vaccines, ISSN 1554-8600, 12/2011, Volume 7, Issue 12, pp. 1343 - 1358
Journal Article
Eurosurveillance, ISSN 1025-496X, 04/2018, Volume 23, Issue 17, pp. 30 - 39
Background: Vaccine hesitancy (VH) is prominent in France. Objectives: This study aimed to estimate the prevalence and socio-demographic correlates of VH in... 
INFECTIOUS DISEASES | ADOLESCENTS | COVERAGE | REASONS | HPV VACCINATION | PARENTS | CHILDHOOD | STRATEGIES | Life Sciences | Human health and pathology | Infectious diseases
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0160099
The objective of this study was to determine the prevalence and some predictors for vaccine and non-vaccine types of HPV infections among bivalent HPV... 
HUMAN-PAPILLOMAVIRUS TYPES | HIV | EFFICACY | HIGH COVERAGE | MULTIDISCIPLINARY SCIENCES | INVASIVE CERVICAL-CANCER | VISUAL INSPECTION | PREVALENCE | ACETIC-ACID | KAMPALA | HPV TYPES | Mass Vaccination | Human papillomavirus 18 - immunology | Coinfection | Prevalence | HIV Infections - epidemiology | Humans | Immunization Programs - organization & administration | Uganda - epidemiology | Human papillomavirus 16 - drug effects | Human papillomavirus 16 - immunology | Young Adult | HIV Infections - microbiology | Papillomavirus Infections - immunology | Female | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Genotype | Syphilis - epidemiology | Syphilis - microbiology | Pilot Projects | Human papillomavirus 18 - drug effects | Papillomavirus Infections - prevention & control | Adolescent | Human papillomavirus 16 - genetics | Care and treatment | Vaccination | Causes of | Genetic aspects | Research | Comparative analysis | Health aspects | Papillomavirus infections | Immunization | Urban areas | CD8 antigen | Health risks | Infections | Vaccines | Risk analysis | Girls | Risk factors | CD4 antigen | Sexually transmitted diseases | Human papillomavirus | Genotyping | Body mass | Womens health | Syphilis | Strains (organisms) | Sexual partners | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Sexually Transmitted Diseases, ISSN 0148-5717, 04/2018, Volume 45, Issue 4, pp. 260 - 265
BACKGROUNDWe examined non–vaccine-type human papillomavirus (HPV) prevalence in a community before and during the first 8 years after vaccine introduction, to... 
INFECTIOUS DISEASES | EFFICACY | PARTICLE VACCINE | PROGRAMS | OF-STUDY ANALYSIS | CERVICAL INFECTION | BLIND PATRICIA TRIAL | HERD-IMMUNITY | YOUNG-WOMEN | HPV-16/18 AS04-ADJUVANTED VACCINE | HPV TYPES
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 12/2018, Volume 84, Issue 12, pp. 2928 - 2932
Aims Human papillomavirus (HPV) vaccines prevent infection with oncogenic virus types. We analysed reports to the US Vaccine Adverse Event Reporting System... 
vaccine safety | immunization | bivalent human papillomavirus vaccine (2vHPV) | vaccine adverse event reporting system (VAERS) | vaccination | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | Papillomaviruses | Safety and security measures | Analysis | Vaccination | Vaccines | Data mining | Health aspects | Papillomavirus infections
Journal Article
Human Vaccines & Immunotherapeutics, ISSN 2164-5515, 07/2013, Volume 9, Issue 7, pp. 1399 - 1406
Journal Article